7:00 – 8:15 AM

Sunrise CME Symposium

Challenging the Status-Quo: Cardiorenal Protection with SGLT-2 Inhibitors in T2DM and Beyond--Expert Debate and Discussions

Chair: George L. Bakris, MD

Faculty: Robert H. Eckel, MD; Stephen D. Wiviott, MD, FACC

Supported by an educational grant from AstraZeneca.

SESSION I: OBESITY AND LIFESTYLE MEDICINE

8:20 – 8:25 AM

Chair Introduction and Opening Remarks

Robert H. Eckel, MD

8:25 – 8:45 AM

Exercise: A Practical Approach

John M. Jakicic, PhD

8:45 – 9:05 AM

Challenges and Advances in Obesity Pharmacotherapy

Ken Fujioka, MD

9:05 – 9:25 AM

The Spectrum of NAFLD and NASH: What the Primary Care Clinician, Endocrinologist, and Cardiologist Should Know

Christos S. Mantzoros, MD, DSc

9:25 – 9:55 AM

Keynote
The Practical Management of Obesity

Robert F. Kushner, MD

9:55 – 10:25 AM

Virtual Exhibit Hall Break

10:25 – 10:30 AM

Introduction: Expert Debates in Nutrition

Robert H. Eckel, MD

10:30 – 11:10 AM

Part I: Digging Through Nutritional Controversies in Cardiometabolic Health

Monica Aggarwal, MD, FACC; Ronald M. Krauss, MD; Alice H. Lichtenstein, D.Sc.

11:10 – 11:30 AM

Part II: Panel Discussion and Q&A

Chair: Robert H. Eckel, MD

Panelists: Monica Aggarwal, MD, FACC; Ronald M. Krauss, MD; Alice H. Lichtenstein, D.Sc.

11:30 AM

Closing Remarks

Robert H. Eckel, MD

11:30 - 11:45 AM

Refresh and Recharge

11:45 AM – 12:45 PM

Virtual PME Symposium (NON–CME)

The Continuum of Heart Failure

Pam R. Taub, MD

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA.

12:45 - 1:00 PM

Active Stretch Session with NASM-Certified Fitness

Instructor: Aria Aloi

SESSION II: DIABETES MANAGEMENT

1:00 – 1:05 PM

Chair Introduction

Anne L. Peters, MD

1:05 – 1:30 PM

Metabolic Surgery: Beyond Weight Control– Its Role in Diabetes Remission

Robert E. Ratner, MD

1:30 –1:55 PM

Prediabetes: How Can We Delay the Progression to Diabetes – Implications for Frontline Clinicians

Leigh Perreault, MD

1:55 – 2:20 PM

Type 2 Diabetes in Children and Young Adults – Lessons from the RISE Studies

Steven E. Kahn, MB, ChB

2:20 – 2:50 PM

Type 2 Diabetes Management When Cost and Access Are an Issue: a 2020 Update

Robert E. Ratner, MD

2:50 – 3:20 PM

Virtual Exhibit Hall Break

3:20 – 3:40 PM

Intensive Glucose Control for T2DM: A 2020 Update

Athena Philis-Tsimikas, MD

3:40 – 4:10 PM

Translating Evidence to Practice Debate: Which comes first, GLP–1 RAs or SGLT–2 Inhibitors in Patients with T2D and Cardiovascular Disease?

Vanita Aroda, MD;Tracy Y. Wang, MD

4:10 – 4:45 PM

Expert Panel Discussion and Q&A

Chair: Anne L. Peters, MD

Panelists: Vanita Aroda, MD; Robert H. Eckel, MD; Steven E. Kahn, MB, ChB; Leigh Perreault, MD; Athena Philis-Tsimikas, MD; Robert E. Ratner, MD; Tracy Y. Wang, MD

4:45 PM

Closing Remarks

Anne L. Peters, MD

7:00 – 8:15 AM

Sunrise CME Symposium

The Evolving Landscape of LDL-C Reduction: Novel Therapies and Approaches

Chair: Christie M. Ballantyne, MD
Faculty: Pam R. Taub, MD; Salim S. Virani, MD, PhD, FACC, FAHA

Supported by an educational grant from Esperion Therapeutics, Inc

SESSION III: KIDNEY DISEASE/HEART FAILURE/HYPERTENSION

8:15 – 8:20 AM

Chair Introduction

George L. Bakris, MD

8:20 – 9:00 AM

Resistant Hypertension: Diagnosis and Management

John Flack, MD

9:00 – 9:40 AM

Challenging Cases/Issues in Hypertension

Raymond R. Townsend, MD; Michael A. Weber, MD

9:40 – 10:10 AM

Virtual Exhibit Hall Break

10:10 – 10:40 AM

Advances in the Prevention and Treatment of HF

Clyde W. Yancy, MD, MSc, MACP

10:40 – 11:10 AM

Improving Renal Outcomes with SGLT–2 Inhibitors and GLP–1 RAs

George L. Bakris, MD

11:10 – 11:35 AM

Expert Panel Discussion and Q&A

Moderator: George L. Bakris, MD

Panelists: John Flack, MD; Raymond R. Townsend, MD; Michael A. Weber, MD; Clyde W. Yancy, MD, MSc, MACP

11:35 - 11:50 AM

Refresh and Recharge

11:50 AM – 12:50 PM

Virtual PME Symposium (NON–CME)

VASCEPA® (icosapent ethyl): Elevating the Standard of Care

John Canto, MD, MSPH

Sponsored by Amarin Pharma, Inc.

12:50 - 1:05 PM

Active Stretch Session with NASM-Certified Fitness

Instructor: Aria Aloi

SESSION IV: DYSLIPIDEMIA/ATHEROSCLEROSIS/THROMBOSIS

1:05 – 1:10 PM

Chair Introduction

Christie M. Ballantyne, MD

1:10 – 1:40 PM

Individualizing Lipid Therapy: From Evidence to Practice

Salim S. Virani, MD, PhD, FACC, FAHA

1:40 – 2:00 PM

Statin Drug–Drug Interactions in Cardiovascular Patients: An Underappreciated Issue

Barbara S. Wiggins, PharmD, FACC

2:00 – 2:30 PM

Update on Secondary CHD Prevention Beyond LDL-C: TGs, Lp(a), and Inflammation

Christie M. Ballantyne, MD

2:30 – 3:00 PM

Virtual Exhibit Hall Break

3:00 – 3:30 PM

Opportunities for ASCVD Prevention and Treatment in Individuals of South Asian Ancestry

Pam R. Taub, MD

3:30 – 4:10 PM

Update on Antiplatelet and Antithrombotic Therapy in the Cardiometabolic Patient

Roxana Mehran, MD

Supported by an educational grant from AstraZeneca.

4:10 – 4:30 PM

Expert Panel Discussion and Q&A

Moderator: Christie M. Ballantyne, MD

Panelists: Robert H. Eckel, MD; Roxana Mehran, MD; Pam R. Taub, MD; Salim S. Virani, MD, PhD, FACC, FAHA; Barbara S. Wiggins, PharmD, FACC

4:30 PM

Meeting Closing Remarks

Christie M. Ballantyne, MD

7:25 – 7:30 AM

Introduction and Opening Remarks

Robert H. Eckel, MD

7:30 – 8:00 AM

Cardiometabolic Medicine Subspecialty: The Future is Now.

Robert H. Eckel, MD

8:00 – 8:30 AM

How Much Prevention Can a Patient Take?

Pamela B. Morris, MD

8:30 – 9:00 AM

Complexities of CVD Prevention and Care in Women

Martha Gulati, MD

9:00 – 11:00 AM

Tackling the Complexity of Cardiometabolic Care: Challenging Patient Cases & Interactive Panel Discussion

Chair: Robert H. Eckel, MD

Panelists: George L. Bakris, MD; Christie M. Ballantyne, MD; Martha Gulati, MD; Pamela B. Morris, MD; Anne L. Peters, MD

11:00 – 11:05 AM

Closing Remarks

Robert H. Eckel, MD